Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Magnussen, C, Saner, C, Burgner, D, Juonala, M, Sabin, M.
Longitudinal association between NMR metabolomic lipid profiles and carotid intima-media thickness among youth with severe obesity.
Atherosclerosis
379:
s46
2023
view publication
Zheng, M, Hesketh, KD, Vuillermin, P, Dodd, J, Wen, LM, Baur, LA, Taylor, R, Byrne, R, Mihrshahi, S, Burgner, D, et al.
Understanding the pathways between prenatal and postnatal factors and overweight outcomes in early childhood: a pooled analysis of seven cohorts..
Int J Obes (Lond)
47(7)
:
574 -582
2023
view publication
Ravindra, D, Huang, G, Hallett, K, Burgner, DP, Gwee, A, Silva, MJ.
Antibiotic Exposure and Dental Health: A Systematic Review..
Pediatrics
152(1)
:
2023
view publication
Saner, C, Senior, AM, Zhang, H, Eloranta, A-M, Magnussen, CG, Sabin, MA, Juonala, M, Janner, M, Burgner, DP, Schwab, U, et al.
Evidence for protein leverage in a general population sample of children and adolescents..
Eur J Clin Nutr
77(6)
:
652 -659
2023
view publication
Ortiz-Fernández, L, Carmona, EG, Kerick, M, Lyons, P, Carmona, FD, López Mejías, R, Khor, CC, Grayson, PC, Tombetti, E, Jiang, L, et al.
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing..
Ann Rheum Dis
82(6)
:
837 -847
2023
view publication